Botulinum toxin injections for the treatment of spasmodic dysphonia

Cochrane Database of Systematic Reviews

Volumn 2010, Issue 1, 2004, Pages

  Watts, Christopher ^a   Whurr, Renata ^b   Nye, Chad ^c  

^a TEXAS CHRISTIAN UNIVERSITY   (United States)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c UNIVERSITY OF CENTRAL FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN;

HUMAN; LARYNX DISORDER; MUSCLE SPASM; REVIEW;

BOTULINUM TOXINS; HUMANS; SPASM; VOICE DISORDERS;

EID: 84921704733     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004327.pub2     Document Type: Review

References (95)

1. Troung D, Rontal M, Rolnick M, Aronson A, Mistura K. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia. Laryngoscope 1991;101:630-4.
2. American Academy of Neurology Therapeutics and Technology Assessment Subcommittee. Assessment: the clinical usefulness of botulinum toxin-A in treating neurologic disorders. Neurology 1990;40:1332-6.
3. Adams SG, Hunt EJ, Charles DA, Lang AE. Unilateral versus bilateral botulinum toxin injections in spasmodic dysphonia: acoustic and perceptual results. The Journal of Otolaryngology 1993;22(3):171-5.
4. Adams SG, Hunt EJ, Irish JC, Charles DA, Lang AE, Durkin LC, Wong DLH. Comparison of botulinum toxin injection procedures in adductor spasmodic dysphonia. Journal of Otolaryngology 1995;24(6):345-51.
5. Adams SG, Durkin LC, Irish JC, Wong DL, Hunt EJ. Effects of botulinum toxin type A injections on aerodynamic measures of spasmodic dysphonia. Laryngoscope 1996;106:296-300.
6. Aronson AE, McCaffrey TV, Litchey WJ, Lipton RJ. Botulinum toxin injection for adductor spasmodic dysphonia: patient self-ratings of voice and phonatory effort after three successive injections. Laryngoscope 1993;103:683-92.
7. Benninger MS, Gardner G, Grywalski C. Outcomes of botulinum toxin treatment for patients with spasmodic dysphonia. Archives of Otolaryngology - Head & Neck Surgery 2001;127:1083-5.
8. Bhattacharyya N, Tarsy D. Impact on quality of life of botulinum toxin treatments for spasmodic dysphonia and oromandibular dystonia. Archives of Otolaryngology - Head and Neck Surgery 2001;127:389-92.
9. Bielamowicz S, Ludlow CL. Effects of botulinum toxin on pathophysiology in spasmodic dysphonia. Annals of Otology, Rhinology, Laryngology 2000;109:194-203.
10. Bielamowicz S, Bidus K, Squire S, Ludlow CL. Assessment of posterior cricoarytenoid botulinum toxin injections in patients with abductor spasmodic dysphonia. The Annals of Otology, Rhinology and Laryngology 2001;110:406-12.
11. Bielamowicz S, Sheila SV, Badillo A, Godlewski A. Unilateral versus bilateral injections of botulinum toxin in patients with adductor spasmodic dysphonia. Journal of Voice 2002;16(1):117-23.
12. Blitzer A, Lovelace RE, Brin MF, Fahn S, Fink ME. Electromyographic findings in focal laryngeal dystonia (spasmodic dysphonia). Annals of Otology, Rhinology, Laryngology 1985;94(6):591-4.
13. Blitzer A, Brin MF, Fahn S, Lovelace RE. Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia). Laryngoscope 1988;98(2):193-7.
14. Blitzer A, Brin MF. Laryngeal dystonia: a series with botulinum toxin therapy. Annals of Otology, Rhinology, & Laryngology 1991;100:85-9.
15. Blitzer A, Brin MF, Stewart C, Aviv JE, Fahn S. Abductor laryngeal dystonia: a series treated with botulinum toxin. Laryngoscope 1992;102:163-7.
16. Blitzer A, Brin MF. Treatment of spasmodic dysphonia (laryngeal dystonia) with local injections of botulinum toxin. Journal of Voice 1992;6(4):365-9.
17. Blitzer A, Brin MF, Stewart CF. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients. Laryngoscope 1998;108:1435-41.
18. Brin MF, Fahn S, Moskowitz C, Friedman A, Shale HM, Greene PE, Blitzer A, List T, Lange D, Lovelace RE. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Advances in Neurology 1988;50:599-608.
19. Brin MF, Blitzer A, Fahn S, Gould W, Lovelace RE. Adductor laryngeal dystonia: treatment with local injections of botulinum toxin. Movement Disorders 1989;4(4):287-96.
20. Brin MF, Blitzer A, Stewart C. Laryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxin. Advances in Neurology 1998;78:237-52.
21. Brin MF, Blitzer A, Stewart CF, Diamond B, Pogoda JM. Botulinum toxin type A for adductor spasmodic dysphonia (laryngeal dystonia): double blind placebo controlled assessment of dose and technique. Neurology 2001;56(8 (Suppl 3)):A346.
22. Cannito MP, Murry T, Woodson GE. Attitudes toward communication in adductor spasmodic dysphonia before and after botulinum toxin injection. Journal of Medical Speech-Language Pathology 1994;2(2):125-33.
23. Ceballos Bauman AG. Spasmodic dysphonia: clinical features and treatment with laryngeal botulinum toxin. Otolaryngology, Rhinology, Laryngology 1992;2(1):33-8.
24. Courey MS, Garrett CG, Portell MS, Billante, CR, Smith TL, Stone RE, Netterville JL. Outcomes assessment following treatment of spasmodic dysphonia with botulinum toxin. Annals of Otology, Rhinology and Laryngology 2000;109:819-22.
25. Crevier-Buchman L, Laccourreye O, Papon JF, Nurit D, Brasnu D. Adductor spasmodic dysphonia: case reports with acoustic analysis following botulinum toxin injection and acupuncture. Journal of Voice 1997;11(2):232-7.
26. Cyrus CB, Bielamowicz S, Evans FJ, Ludlow CL. Adductor muscle activity abnormalities in abductor spasmodic dysphonia. Otolaryngology - Head and Neck Surgery 2001;124(1):23-30.
27. Davidson BJ, Ludlow CL. Long-term effects of botulinum toxin injections in spasmodic dysphonia. Annals of Otology, Rhinology and Laryngology 1996;105:33-42.
28. Devriese PP, Speelman JD. The treatment of vocal-cord dyskinesia with botulinum toxin. Nederlands Tijdschrift voor Geneeskunde 1994;138(19):944-7.
29. Finnegan E, Luschei E, Gordon J, Barkmeier J, Hoffman H. Increased stability of airflow following botulinum toxin injection. Laryngoscope 1999;109:1300-6.
30. Fisher KV, Scherer RC, Guo CG, Owen AS. Longitudinal phonatory characteristics after botulinum toxin injection. Journal of Speech and Hearing Research 1996;39:968-80.
31. Fisher KV, Scherer RC, Swank PR, Giddens CG, Patten D. Electroglottographic tracking of phonatory response to Botox. Journal of Voice 1999;13(2):203-9.
32. Ford CN, Bless DM, Lowery JD. Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia. Otolaryngology - Head Neck Surgery 1990;103:752-8.
33. Ford CN, Bless DM, Patel NY. Botulinum toxin treatment of spasmodic dysphonia: techniques, indications, efficacy. Journal of Voice 1992;6(4):370-6.
34. Galardi G, Guerriero R, Amadio S, Leocani L, Teggi R, Mellani G, Comi G. Sporadic failure of botulinum toxin treatment in usually responsive patients with adductor spasmodic dysphonia. Neurological Sciences 2001;22(4):303-6.
35. George EF, Zimbler M, Wu BL, Biller HF, Sanders I. Quantitative mapping of the effect of botulinum toxin injections in the thyroarytenoid muscle. Annals of Otology, Rhinology, Laryngology 1992;101(11):888-92.
36. Green DC, Ward PH, Berke GS, Gerratt BR. Point-touch technique of botulinum toxin injection for the treatment of spasmodic dysphonia. Annals of Otology, Rhinology and Laryngology 1992;101:883-7.
37. Inagi K, Ford CN, Bless DM, Heisey D. Analysis of factors affecting botulinum toxin results in spasmodic dysphonia. Journal of Voice 1996;10(3):306-13.
38. Jankovic J, Schwartz K, Donovan D. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, and other focal dystonias and hemifacial spasm. Journal of Neurology, Neurosurgery and Psychiatry 1990;53:633-9.
39. Klap P, Marion MH, Perrin A, Fresnel-Elbaz E. Treatment of spasmodic dysphonia with botulinum toxin [Traitement de la dysphonie spasmodicque par la toxine botulique]. Annales d'Oto-laryngologie et de Chirurgie Cervico Faciale 1991;108:477-83.
40. Klap P, Marion MH, Perrin A, Fresnel-Elbaz E, Cohen M. Indications of botulinus toxin in laryngology. Revue de Laryngologie 1993;114(4):281-7.
41. Kobayashi T, Miimi S, Kumada M, Kosaki H, Hirose H. Botulinum toxin treatment for spasmodic dysphonia. Acta Otolaryngologica 1993;504 (supp):155-7.
42. Koriwchak MJ, Netterville JL, Snowden T, Courey M, Ossoff RH. Alternating unilateral botulinum toxin type A (BOTOX) injections for spasmodic dysphonia. Laryngoscope 1996;106:1476-81.
43. Langeveld TP, Drost HA, Baatenburg de Jong RJ. Unilateral versus bilateral botulinum toxin injections in adductor spasmodic dysphonia. Annals of Otology, Rhinology and Laryngology 1998;107:280-4.
44. Langeveld TP, Edgar HH, Jeroen JB, Van Rossum M, Zwinderman AH, Baatenburg RJ. Evaluation of voice quality in adductor spasmodic dysphonia before and after botulinum toxin treatment. Annals of Otology, Rhinology and Laryngology 2001;110:627-34.
45. Lees AJ, Turjanski N, Rivest J, Whurr R, Lorch M, Brookes G. Treatment of cervical dystonia hand spasms and laryngeal dystonia with botulinum toxin. Journal of Neurology 1992;239:1-4.
46. Liu TC, Irish JC, Adams SG, Durkin LC, Hunt EJ. Prospective study of patients' subjective responses to botulinum toxin injection for spasmodic dysphonia. The Journal of Otolaryngology 1996;25(2):66-74.
47. Loven J, Brondbo K, Ganes T. Botulinum toxin. A new therapeutic alternative in spastic dysphonia (laryngeal abductor dystonia) [Et nytt behandlingsalternativ ved spastisk dysfoni (laryngeal adduktordystoni)]. Tidsskr for den Norske laegeforening: tidsskrift for praktisk 1993;113(7):841-3.
48. Loven JO, Brondbo K, Ganes T, Tveteras G, Frydenbo J. Botulinum toxin treatment for spasmodic dysphonia (adductor laryngeal dystonia): Experience with 31 patients. Scandinavia Journal of Logopedics & Phoniatrics 1994;19:107-11.
49. Ludlow CL, Naunton RF, Sedory SE, Schulz GM, Hallett M. Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia. Neurology 1988;38:1220-5.
50. Ludlow CL, Naunton RF, Fujita M, Sedory SE. Spasmodic dysphonia: botulinum toxin injection after recurrent nerve surgery. Otolaryngology - Head and Neck Surgery 1990;102:122-31.
51. Ludlow CL, Naunton RF, Terada S, Anderson BJ. Successful treatment of selected cases of abductor spasmodic dysphonia using botulinum toxin injection. Otolaryngology - Head and Neck Surgery 1991;104:849-55.
52. Ludlow CL, Bagley J, Yin SG, Koda J. A comparison of injection techniques using botulinum toxin injection for treatment of the spasmodic dysphonias. Journal of Voice 1992;6(4):380-6.
53. Lundy DS, Ling Lu F, Casiano RR, Xue JW. The effect of patient factors on response outcomes to botox treatment for spasmodic dysphonia. Journal of Voice 1998;4:460-6.
54. Maloney AP, Morrison MD. A comparison of the efficacy of unilateral versus bilateral botulinum toxin injections in the treatment of adductor spasmodic dysphonia. The Journal of Otolaryngology 1994;23(3):160-4.
55. Marion MH, Perrin KA, Elbaz E. Les dysphonies spasmodiques: methodes d'investigation et de traitement. Rev. Neurol. (Paris) 1992;148(3):180-3.
56. Maurri S Barontini F. Botulinum toxin. A new therapeutic alternative in spastic dysphonia (laryngeal abductor dystonia) [Breve aggiornamento sulla tereapia della disfonia spasmodica. Efficacia della tossina botulinnica purificata di tipo]. Nuova Rivista di Neurologia 1992;3(1):35-8.
57. Mehta RP, Goldman SN, Orloff LA. Long-term therapy for spasmodic-dysphonia: acoustic and aerodynamic outcomes. Archives of Otolaryngology - Head and Neck Surgery 2001;127:393-9.
58. Meleca RJ, Hogikyan ND, Bastian RW. A comparison of methods of botulinum toxin injection for abductory spasmodic dysphonia. Otolaryngology - Head and Neck Surgery 1997;117:487-92.
59. Miller RH, Woodson GE, Jankovic J. Botulinum toxin injection of the vocal fold for spasmodic dysphonia. Archives of Otolaryngology - Head and Neck Surgery 1987;113:603-5.
60. Murry T, Woodson GE. Combined-modality treatment of adductor spasmodic dysphonia with botulinum toxin and voice therapy. Journal of Voice 1995;9(4):460-5.
61. Papathanasiou I, MacDonald L, Whurr R, Brookes G, Jahanshahi M. Perceived stigma among patients with spasmodic dysphonia. Journal of Medical Speech-Language Pathology 1997;5(4):251-61.
62. Poungvarin N, Devahastin V, Viriyavejakul A. Treatment of various movement disorders with botulinum toxin A injection: an experience of 900 patients. Journal of the Medical Association of Thailand 1995;78(6):281-7.
63. Rhew K, Fiedler DA, Ludlow CL. Technique for injection of botulinum toxin through the flexible nasolaryngoscope. Otolaryngology - Head and Neck Surgery 1994;111:787-94.
64. Rodriguez AA, Ford CN, Bless DM, Harmon RL. Electromyographic assessment of spasmodic dysphonia patients prior to botulinum toxin injection. Electromyography & Clinical Neurophysiology 1994;34:403-7.
65. Rontal M, Rontal E, Rolnick M, Merson R, Silverman B, Truong D. A method for the treatment of abductor spasmodic dysphonia with botulinum toxin injections: a preliminary report. Laryngoscope 1991;101:911-4.
66. Rosen CA, Murry T. Botox for hyperadduction of the false vocal folds: a case report. Journal of Voice 1999;13:234-9.
67. Ruiz PJG, Bernardos VS, Astarloa R, Sanabria J, de Yebenes JG. Botulinum toxin treatment for spasmodic dysphonia: percutaneous versus transoral apporach. Clinical Neuropharmacology 1998;21(3):196-8.
68. Sapienza CM, Cannito MP, Murry T, Branski R, Woodson G. Acoustic variations in reading produced by speakers with spasmodic dysphonia pre-botox injection and within early stages of post-botox injection. Journal of Speech, Language and Hearing Research 2002;45:830-43.
69. Schonweiler R, Wohlfarth K, Dengler R, Ptok M. Supraglottal injection of botulinum toxin type A in adductor spasmodic dysphonia with both intrinsic and extrinsic hyperfunction. Laryngoscope 1998;108:55-63.
70. Smith ME, Ford CN. Resistance to botulinum toxin injections for spasmodic dysphonia. Archives of Otolaryngology - Head and Neck Surgery 2000;126(4):533-5.
71. Teive HAG, Scola HS, Werneck LC, de Quadros A, Gasparetto EL, Sa DS, Brandi IV, Filho EDM. Use of botulinum toxin in the treatment of laryngeal dystonia (spasmodic dysphonia): preliminary study of twelve patients. Arquivos de Neuro-psiquiatria 2001;59(1):97-100.
72. Thomas JP, Siupsinskiene N. Frozen versus fresh reconstituted botox for laryngeal dystonia. Otolaryngology - Head and Neck Surgery 2006;135(2):204-8.
73. Tish SH, Brake HM, Law M, Cole IE, Darveniza P. Spasmodic dysphonia: clinical features and effects of botulinum toxin therapy in 169 patients - an Australian experience. Journal of Clinical Neuroscience 2003;10(4):434-8.
74. Whurr R, Lorch M, Fontana H, Brookes G, Lees A, Marsden CD. The use of botulinum toxin in the treatment of adductor spasmodic dysphonia. Journal of Neurology, Neurosurgery and Psychiatry 1993;56:526-30.
75. Whurr R, Lorch M, Nye C. The treatment of spasmodic dysphonia with botulinum toxin. Neurology Reviews International 1997;2:11-15.
76. Whurr R, Lorch M, Lindsay M, Brookes G, Marsden C. Psychological function in spasmodic dysphonia before and after treatment with botulinum toxin. Journal of Medical Speech-Language Pathology 1998;2:81-91.
77. Wong DLH, Irish JC, Adams SG, Durkin LC, Hunt EJ. Laryngeal image analysis following botulinum toxin injections in spasmodic dysphonia. Journal of Otolaryngology 1995;24(1):64-8.
78. Wong DL, Adams SG, Irish JC, Durkin LC, Hunt EJ, Charlton MP. Effect of neuromuscular activity on the response to botulinum toxin injections in spasmodic dysphonia. The Journal of Otolaryngology 1995;24(4):209-16.
79. Zwirner P, Murry T, Swenson M, Woodson GE. Acoustic changes in spasmodic dysphonia after botulinum toxin injection. Journal of Voice 1991;5(1):78-84.
80. Zwirner P, Murry T, Swenson M, Woodson GE. Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: acoustic, aerodynamic and videoendoscopic findings. Laryngoscope 1992;102:400-6.
81. Zwirner P, Murry T, Woodson GE. A comparison of bilateral and unilateral botulinum toxin treatments for spasmodic dysphonia. European Archives of Otorhinolaryngology 1993;250:271-6.
82. Zwirner P, Murry T, Woodson GE. Perceptual-acoustic relationships in spasmodic dysphonia. Journal of Voice 1993;7(2):165-71.
83. Zwirner P, Murry T, Woodson GE. Effects of botulinum toxin on vocal tract steadiness in patients with spasmodic dysphonia. European Archives of Otorhinolaryngology 1997;254:391-5.
84. Aronson A. Clinical Voice Disorders: An Interdisciplinary Approach. New York: Thieme, 1990.
85. Blitzer A, Sulica L. Botulinum toxin: basic science and clinical uses in otolaryngology. The Laryngoscope 2001;111:218-26.
86. Boone D, McFarlane S. The Voice and Voice Therapy. Boston: Allyn & Bacon, 2000.
87. Boutsen F, Cannito M, Taylor M, Bender B. Botox treatment for adductor spasmodic dysphonia: a meta-analysis. Journal of Speech, Language and Hearing Research 2002;45:469-81.
88. Brin M, Blitzer A, Stewart C. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12 year experience in more than 900 patients. The Laryngoscope 1998;98:193-7.
89. Cannito M, Johson P. Spastic dysphonia: a continuum disorder. Journal of Communication Disorders 1981;14:215-23.
90. Cannito M. Neurological aspects of spasmodic dysphonia. In: Vogel D, Cannito M editor(s). Treating Disordered Speech Motor Control. Austin: Pro-Ed, 2001.
91. Drost HA, Baatenburg de Jong RJ. Unilateral versus bilateral botulinum toxin injections in adductor spasmodic dysphonia. Annalos of Otology, Rhinology and Laryngology 1998;107:280-4.
92. Duffy JR, Yorkston K. Medical interventions for spasmodic dysphonia and some related conditions: a systematic review. Journal of Medical Speech Language Pathology 2003;11(4):ix-lviii.
93. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
94. The Nordic Cochrane Centre. The Cochrane Collaboration. Review Manager (RevMan). Version 5.0. Copenhagen: The Nordic Cochrane Centre. The Cochrane Collaboration, 2008.
95. Stemple J. Voice Therapy: Clinical Studies. San Diego: Singular, 2000.